Workflow
启迪药业(000590) - 2017 Q3 - 季度财报
TUS-PHARMATUS-PHARMA(SZ:000590)2017-10-26 16:00

Financial Performance - Operating revenue decreased by 4.68% to CNY 59,039,130.94 for the current period compared to the same period last year[8] - Net profit attributable to shareholders increased by 62.81% to CNY 634,852.89 for the current period compared to the same period last year[8] - Basic earnings per share increased by 64.71% to CNY 0.0028 for the current period compared to the same period last year[8] - The weighted average return on net assets was 0.11%, a decrease of 0.07% compared to the same period last year[8] - Non-recurring gains and losses totaled CNY 3,167,178.98 for the year-to-date period[9] Assets and Liabilities - Total assets increased by 29.32% to CNY 815,603,225.60 compared to the end of the previous year[8] - Net assets attributable to shareholders increased by 112.56% to CNY 554,721,921.00 compared to the end of the previous year[8] - Accounts receivable increased by 108.32% to ¥4,057,966.70 due to credit impact on sales[16] - Other current assets surged by 622,236.79% to ¥194,067,566.18 as a result of purchasing financial products during the reporting period[16] - Construction in progress rose by 154.60% to ¥23,444,334.44, primarily due to increased investment in projects[16] - Short-term borrowings decreased by 94.89% to -¥74,300,000.00, attributed to reduced discounted notes and repayment of bank loans[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 12,167[12] - The largest shareholder, Tsinghua Tongfang Co., Ltd., holds 24.71% of the shares[12] - The company did not conduct any repurchase transactions during the reporting period[13] Cash Flow and Financing Activities - Cash flow from operating activities net amount decreased by 349.80% to -¥65,486,038.61, mainly due to reduced cash received from sales[16] - Total cash inflow from financing activities increased by 380.21% to ¥237,683,179.21, primarily due to the completion of a private placement of shares[17] Social Responsibility and Community Support - The company provided support funds of 38,500 yuan to assist 7 impoverished households during the third quarter[28] - The company is focusing on poverty alleviation through housing reconstruction and education support in the second half of 2017[31] - The company has completed preliminary field research for the establishment of a health preservation raw material planting and collection base in Xianghu Village, enhancing its industrial poverty alleviation efforts[31]